developing biomarkers and treatments for chronic joint diseases
 
Search
 

PROJECT OVERVIEW

An overview of AnaMar's drug and biomarker development projects

DRUG DEVELOPMENT

New disease-modifying anti- rheumatic drugs (DMARDS) that ideally ...

BIOMARKER DEVELOPMENT

Biomarkers that describe the pathogenesis in chronic joint diseases ...
NEWS & REPORTS
Jun 01 2010
Positive Phase I results for AMAP102
Mar 26 2010
New COMP ELISA Focus letter
Dec 01 2009
AMAP102, New Oral Cytokine Inhibitor to Treat Rheumatoid Arthritis - Phase 1 dosing completed , Results in Q1
More news
AnaMar's news feed
© 2010, AnaMar AB, Kungsportsavenyn 22, SE-411 36, Göteborg, Sweden. Phone: +46 31 732 41 40, Fax: +46 31 732 41 49, info@anamar.com
Disclaimer - Privacy policy statement - Terms and conditions of use